+958.0%
MRNA vs FITB
+171.8%
+786.2%
-95.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | FITB | Excess | Alpha |
|---|---|---|---|---|
| 1D | -4.8% | -0.6% | -4.3% | -4.8% |
| 7D | -20.9% | -4.5% | -16.4% | -20.5% |
| 30D | -13.3% | +2.9% | -16.2% | -13.4% |
| 3M | +212.6% | -8.5% | +221.1% | +214.6% |
| 6M | +309.0% | +10.1% | +299.0% | +299.7% |
| YTD | +567.3% | +13.8% | +553.6% | +548.1% |
| 1Y | +689.7% | +29.9% | +659.8% | +652.6% |
| 3Y | +157.4% | +109.9% | +47.6% | +135.1% |
| 5Y | -21.7% | +42.2% | -63.9% | -28.4% |
| All | +958.0% | +171.8% | +786.2% | +1,041.0% |
Cumulative growth
Daily Returns
Daily percentage return beside FITB.
Daily Out/Under-Performance
Portfolio return minus FITB return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × FITB return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded FITB wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling